PT Sun Life Indonesia has announced an exceptional financial performance for the first quarter of 2026, recording a net profit of Rp 97.05 billion. This remarkable achievement represents a robust 104.7% increase compared to the same period last year. The significant surge in net profit for the leading life insurance company is primarily attributed to the strengthened distribution channels, notably through strategic banking partnerships and a robust agency network.
Building on this momentum, the company’s total revenue also saw a substantial rise, climbing from Rp 388.23 billion to Rp 505.76 billion. This impressive revenue growth was mirrored by a healthy increase in premium income, which soared to Rp 944.94 billion from the previous Rp 633.94 billion, underscoring the expanding reach and appeal of Sun Life Indonesia’s offerings.
Albertus Wiroyo, President Director of Sun Life Indonesia, emphasized that this positive financial trajectory is a clear reflection of the escalating trust customers place in the company’s comprehensive suite of products and services. He highlighted the intrinsic link between the company’s performance and its commitment to client satisfaction.
“This stellar performance truly reflects the growing confidence among our customers, and it places a significant responsibility on Sun Life Indonesia to continually deliver solutions that are highly relevant to the evolving needs of society today,” Albertus stated during the press conference for the launch of SHIFA Signature on Friday, May 9.
Wiroyo further elaborated on the pressing societal demand for health protection, which continues to intensify due to the rising health risks and the escalating cost of medical care. This increasing awareness underscores the critical need for robust insurance solutions that can adapt to changing circumstances.
Highlighting the broader market context, he noted that medical cost inflation in Indonesia reached an alarming 19.8% in 2025. Concurrently, there’s a concerning trend of critical illnesses increasingly affecting individuals in their productive years, with many diagnoses occurring even before the age of 40, amplifying the urgency for comprehensive health coverage.
Compounding these challenges is the persistently low life insurance penetration in Indonesia, which currently stands at less than 3% of the Gross Domestic Product (GDP). Data indicates that only about 6.6% of the Indonesian population currently possesses life insurance, revealing a vast untapped market and a critical protection gap.
In response to these pervasive market needs and conditions, Sun Life Indonesia proudly launched its innovative new health protection product, SHIFA Signature. This carefully crafted product is designed to provide complementary family health protection, offering essential coverage even for customers who already benefit from BPJS or corporate insurance schemes, ensuring a more comprehensive safety net.
SHIFA Signature boasts a wide array of benefits, including extensive inpatient care, surgical procedures, outpatient services related to medical actions, ambulance services, specific vaccinations, and a compassionate death benefit. Additionally, it offers valuable supplementary benefits such as telehealth consultations, home care services, proactive health screenings for stroke and cancer, and even coverage for certain traditional medicine treatments, all subject to specific policy terms.
Customers seeking flexible and extensive coverage can choose from seven distinct protection regions, ranging from Indonesia-only coverage to comprehensive global protection. This versatile product also offers substantial annual health benefits of up to Rp 15 billion, with the added advantage of a Limit Booster that can extend coverage up to Rp 35 billion, providing unparalleled financial security.
Albertus reiterated that SHIFA Signature has been meticulously engineered to address the increasingly diverse and complex health requirements of the Indonesian populace, offering tailored solutions that truly make a difference.
The distribution of this cutting-edge product will leverage Sun Life Indonesia’s established agency channels as well as its robust banking partnerships. These include collaborations with prominent financial institutions such as PT Bank CIMB Niaga Tbk, CIMB Niaga Syariah, and Bank Muamalat Indonesia, ensuring wide accessibility for potential policyholders.
Beyond its conventional offerings, Sun Life Indonesia’s Sharia business unit also demonstrated outstanding growth, reporting a net profit after tax of Rp 28.29 billion. This marks an extraordinary 259.46% surge compared to Rp 7.87 billion recorded in the first quarter of 2025, underscoring the burgeoning success and increasing acceptance of Sharia-compliant financial solutions. The net contribution from the Sharia business unit further reinforced this positive trend, rising impressively from Rp 68.43 billion to Rp 83.77 billion.
Summary
PT Sun Life Indonesia achieved a net profit of IDR 97.05 billion in the first quarter of 2026, marking a 104.7% increase driven by strong banking partnerships and a growing agency network. Total revenue rose to IDR 505.76 billion, while premium income surged significantly to IDR 944.94 billion. Additionally, the company’s Sharia business unit experienced exceptional growth, with net profit after tax soaring by 259.46% compared to the previous year.
To address the rising demand for comprehensive health coverage and combat medical inflation, the company launched its new product, SHIFA Signature. This offering provides flexible protection options, ranging from local to global coverage with limits up to IDR 35 billion, and includes features like telehealth and home care services. The product is now available through Sun Life’s established agency channels and strategic partnerships with major financial institutions like CIMB Niaga and Bank Muamalat.